Prescribed Innovation: Financing the Future of Digital Health
summary
Europe spends ~10% of GDP on healthcare (~€300–400bn/year) while digital uptake lags; Germany has 90 statutory insurers and fragmented data that block scaling. One insurer shifts from payer to investor and partners, offering venture funding, selective contracts, and an eCare electronic patient record to pilot solutions. A startup (founded 2024, team ~7) ships a smart food-and-symptom diary plus nutrition experts, is a certified medical device, and faces the funding–certification catch‑22 and limited national rollout paths.
AI-written summary · about
chapters (11)
- 0:00Digital health innovation challenges
- 3:34Barmer’s health tech role
- 6:25Vatia’s food intolerance solution
- 8:09Health tech financing hurdles
- 10:59Startup-insurer partnerships
- 14:31Reimbursement systems Germany vs France
- 17:25Why Vatia skipped DiGA
- 19:13Evaluating DiGA impact
- 21:46Future of selective contracts
- 22:50Barmer’s competitive edge
- 24:35Final wishes for health tech
